^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    MelaNodal Predict™

    Company:
    Quest Diagnostics
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    3ms
    Quest Diagnostics debuts MelaNodal Predict™ Test, personalizing melanoma risk prediction to help patients forgo invasive surgery (Quest Diagnostics Press Release)
    "Quest Diagnostics...announced the launch of MelaNodal Predict™, a highly advanced predictive gene expression test to help personalize treatment decisions for patients with melanoma, the deadliest form of skin cancer and one of the most common cancers in the United States. Dermatologists and other providers nationwide may begin ordering the test today from Quest Diagnostics, as well as through Dermpath Diagnostics, Quest's subspecialty pathology business."
    Launch
    |
    MelaNodal Predict™